Journal
METABOLITES
Volume 12, Issue 11, Pages -Publisher
MDPI
DOI: 10.3390/metabo12111044
Keywords
miRNA; serum; plasma; obesity; type 2 diabetes; metabolic syndrome
Categories
Funding
- Sao Paulo Research Foundation-FAPESP [2019/22934-1|2020/03104-5]
- National Council for Scientific and Technological Development-CNPq [150834/2020-9|301109/2019-2]
Ask authors/readers for more resources
This systematic review examines the relationships between circulating microRNA and risk factors for Metabolic Syndrome (MetS), and identifies several microRNAs that are strongly associated with MetS risk factors. Circulating microRNA is upregulated in individuals with MetS risk factors and correlates with glycemic, lipid, and adiposity markers.
MicroRNA regulates multiple pathways in inflammatory response, adipogenesis, and glucose and lipid metabolism, which are involved in metabolic syndrome (MetS). Thus, this systematic review aimed at synthesizing the evidence on the relationships between circulating microRNA and risk factors for MetS. The systematic review was registered in the PROSPERO database (CRD42020168100) and included 24 case-control studies evaluating microRNA expression in serum/plasma of individuals >= 5 years old. Most of the studies focused on 13 microRNAs with higher frequency and there were robust connections between miR-146a and miR-122 with risk factors for MetS, based on average weighted degree. In addition, there was an association of miR-222 with adiposity, lipid metabolism, glycemic metabolism, and chronic inflammation and an association of miR-126, miR-221, and miR-423 with adiposity, lipid, and glycemic metabolism. A major part of circulating microRNA was upregulated in individuals with risk factors for MetS, showing correlations with glycemic and lipid markers and body adiposity. Circulating microRNA showed distinct expression profiles according to the clinical condition of individuals, being particularly linked with increased body fat. However, the exploration of factors associated with variations in microRNA expression was limited by the variety of microRNAs investigated by risk factor in diverse studies identified in this systematic review.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available